Zoetis (ZTS) Current Assets (2012 - 2026)
Zoetis' (ZTS) quarterly Current Assets came in at $6.5 billion in Q1 2026, up 10.16% year-on-year from $5.9 billion in Q1 2025, and down 4.41% on a QoQ basis from $6.8 billion in Q4 2025.
Zoetis (ZTS) Current Assets (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Current Assets data on file, last reported at $6.5 billion in Q1 2026.
- On a quarterly basis, Current Assets rose 10.16% year-over-year to $6.5 billion in Q1 2026; TTM through Mar 2026 was $6.5 billion, a 10.16% increase from a year earlier, with the FY2025 full-year figure at $6.8 billion, up 13.15% from the prior year.
- Current Assets for Q1 2026 stood at $6.5 billion, down from $6.8 billion in the prior quarter.
- Over the last five years, Current Assets for ZTS reached as high as $7.5 billion in Q4 2022 and fell as low as $5.9 billion in Q1 2025.
- Historically, Current Assets has averaged $6.4 billion across 5 years, with a median of $6.3 billion in 2023.
- Across the five-year window, Current Assets declined 15.49% in 2023 and advanced 13.15% in 2025, its largest moves.
- Year by year, Current Assets stood at $7.5 billion in 2022, then retreated by 15.49% to $6.3 billion in 2023, then fell by 5.63% to $6.0 billion in 2024, then advanced by 13.15% to $6.8 billion in 2025, then dropped by 4.41% to $6.5 billion in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $6.5 billion in Q1 2026, $6.8 billion in Q4 2025, and $6.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 258.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.47 Bn |
| Dec 31, 2025 | 6.77 Bn |
| Sep 30, 2025 | 6.58 Bn |
| Jun 30, 2025 | 5.92 Bn |
| Mar 31, 2025 | 5.88 Bn |
| Dec 31, 2024 | 5.99 Bn |
| Sep 30, 2024 | 6.28 Bn |
| Jun 30, 2024 | 6.20 Bn |
| Mar 31, 2024 | 6.36 Bn |
| Dec 31, 2023 | 6.34 Bn |
| Sep 30, 2023 | 6.22 Bn |
| Jun 30, 2023 | 6.18 Bn |
| Mar 31, 2023 | 6.27 Bn |
| Dec 31, 2022 | 7.51 Bn |
| Sep 30, 2022 | 6.55 Bn |
| Jun 30, 2022 | 6.65 Bn |
| Mar 31, 2022 | 6.84 Bn |
| Dec 31, 2021 | 6.93 Bn |
| Sep 30, 2021 | 6.68 Bn |
| Jun 30, 2021 | 7.05 Bn |